Status:
UNKNOWN
Augmentation of Maxillary Horizontal And Vertical Bone Deficiency Using Mineralized Plasmatic Matrix
Lead Sponsor:
Cairo University
Conditions:
Alveolar Ridge Abnormality of Maxilla
Eligibility:
All Genders
20-40 years
Phase:
NA
Brief Summary
A new technique of grafting introduce called Mineralized plasmatic matrix. This technique can be used in grafting in anterior zone giving a good results and bone substitution occur using allograft or ...
Detailed Description
Patients suffering from anterior maxillary vertical and horizontal bone loss will be treated using a xeno-graft mixed with the same patient plasma that extracted from his own blood during the operatio...
Eligibility Criteria
Inclusion
- Age: from 20 to 40 years old
- no history of previous grafting.
- no History of previous implant placement
- Medically Free e.g no debilitating diseases
Exclusion
- Smoker patients.
- Alcoholic patients
- Pregnant.
- Drug Abusers.
- Hypertensive , Diabetic, having Problems or disease in Kidney and/or liver.
- Thyroid Disease.
- Problem in Vit.D absorption or in calcitonin hormone secretion.
- History of blood transfusion or donating blood less than 4 months.
- Patient under Corticosteroid therapy.
- Neurologicaly unstable patients.
- History of radiotherapy or chemo-therapy.
- Patient undergo Spect C.T Scan less than 4 Months .
Key Trial Info
Start Date :
November 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 25 2020
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT03757195
Start Date
November 15 2018
End Date
October 25 2020
Last Update
November 28 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo Univerisity
Cairo, Egypt
2
Cairo University
Cairo, Egypt